Buzzatti G - Search Results

1

Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study.

Blondeaux E, Lambertini M, Michelotti A, Conte B, Benasso M, Dellepiane C, Bighin C, Pastorino S, Levaggi A, Alonzo A, Poggio F, Buzzatti G, Molinelli C, Fregatti P, Bertoglio S, Boccardo F, Del Mastro L. Blondeaux E, et al. Among authors: buzzatti g. Br J Cancer. 2020 May;122(11):1611-1617. doi: 10.1038/s41416-020-0816-8. Epub 2020 Mar 31. Br J Cancer. 2020. PMID: 32231293 Free PMC article. Clinical Trial.

2

Periostin: a novel prognostic and therapeutic target for genitourinary cancer?

Nuzzo PV, Buzzatti G, Ricci F, Rubagotti A, Argellati F, Zinoli L, Boccardo F. Nuzzo PV, et al. Among authors: buzzatti g. Clin Genitourin Cancer. 2014 Oct;12(5):301-11. doi: 10.1016/j.clgc.2014.02.005. Epub 2014 Feb 21. Clin Genitourin Cancer. 2014. PMID: 24656869 Review.

3

Safety of antiandrogen therapy for treating prostate cancer.

Ricci F, Buzzatti G, Rubagotti A, Boccardo F. Ricci F, et al. Among authors: buzzatti g. Expert Opin Drug Saf. 2014 Nov;13(11):1483-99. doi: 10.1517/14740338.2014.966686. Epub 2014 Oct 1. Expert Opin Drug Saf. 2014. PMID: 25270521 Review.

4

Immunotherapy for genitourinary cancer: state of the art and new perspectives.

Cattrini C, Dellepiane C, Cavo A, Buzzatti G, Tolomeo F, Messina C, Boccardo F. Cattrini C, et al. Among authors: buzzatti g. Anticancer Drugs. 2016 Aug;27(7):585-99. doi: 10.1097/CAD.0000000000000376. Anticancer Drugs. 2016. PMID: 27183027 Review.

5

Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives.

Messina C, Buzzatti G, Dellepiane C, Cavo A, Tolomeo F, Cattrini C, Boccardo F. Messina C, et al. Among authors: buzzatti g. Anticancer Drugs. 2016 Nov;27(10):917-43. doi: 10.1097/CAD.0000000000000405. Anticancer Drugs. 2016. PMID: 27400375 Review.

6

CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials.

Messina C, Cattrini C, Buzzatti G, Cerbone L, Zanardi E, Messina M, Boccardo F. Messina C, et al. Among authors: buzzatti g. Breast Cancer Res Treat. 2018 Nov;172(1):9-21. doi: 10.1007/s10549-018-4901-0. Epub 2018 Jul 27. Breast Cancer Res Treat. 2018. PMID: 30054831

7

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.

Poggio F, Lambertini M, Bighin C, Conte B, Blondeaux E, D'Alonzo A, Dellepiane C, Buzzatti G, Molinelli C, Boccardo F, Del Mastro L. Poggio F, et al. Among authors: buzzatti g. Clin Med Insights Reprod Health. 2019 Jul 31;13:1179558119864584. doi: 10.1177/1179558119864584. eCollection 2019. Clin Med Insights Reprod Health. 2019. PMID: 31391786 Free PMC article. Review.

8

Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program.

Tini G, Sarocchi M, Sirello D, Murialdo R, Fornarini G, Buzzatti G, Boccardo F, Arboscello E, Porto I, Ameri P, Spallarossa P. Tini G, et al. Among authors: buzzatti g. Eur J Prev Cardiol. 2021 Aug 9;28(9):e38-e40. doi: 10.1177/2047487320923056. Eur J Prev Cardiol. 2021. PMID: 32375549 No abstract available.

9

New emerging targets in cancer immunotherapy: the role of GITR.

Buzzatti G, Dellepiane C, Del Mastro L. Buzzatti G, et al. ESMO Open. 2020 Aug;4(Suppl 3):e000738. doi: 10.1136/esmoopen-2020-000738. ESMO Open. 2020. PMID: 32817129 Free PMC article. Review.

10

[No title available]

[No authors listed] [No authors listed] PMID: 33611422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page